Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Varubi IV’s second-try FDA approval provides CINV patients with a new option
  2. The future of orphan drugs in Europe
  3. Innovative trial design: where regulators and payers divide
  4. Ignyta’s Entrectinib is a game-changer for NTRK/ROS1/ALK fusion-positive solid tumors
  5. Termination of REMS for erythropoiesis-stimulating agents marks end of an era for FDA

Latest Content

Innovative trial design: where regulators and payers divide

There is an increasing movement in the pharmaceutical industry away from traditional trial design as more dynamic and innovative design approaches offer new ways to demonstrate clinical effectiveness. Although these innovative trial designs have been accepted, and in some cases encouraged, by regulators, the same cannot be said for increasingly powerful payers.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top